NASDAQ : AFJK

Aimei Health Technology Co., Ltd

$12 USD

$0 (0.0%)

Volume
17.79K
Average Volume
11.43K
Market Capitalization
$73.46M
P/E Ratio
71.60
Dividend Yield
0.00%
Price Target
Year High
$130.37
Year Low
$6.75
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.01
Company Overview

NASDAQ

Junheng Xie

Shell Companies

Financial Services

AFJK

2

US

USD

212 845 9945

G01341109

0001979005

Liquidity Metrics

0.26

0.01

0.01

0.01

0.00

Sales & Valuation

-$

0.00

1.54

-176.71

-0.40

Profitability

$0.17

$1.06M

0.00%

0.00%

3.69%

7.49%

P/E Metrics

71.60

-3.15

-3.15

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

9.53

4/9

-$3.5M

$12.29M

$4.21M

-$484.33K

Key Metrics (TTM)

$75.09M

0.00

-155.05

0.01

3.69%

-4.46%

7.42%

-0.57%

$12.44

0 days

Company Executives
Name Title
Junheng Xie Chief Executive Officer, Secretary & Director
Heung Ming Wong Chief Financial Officer & Director
Poll Results

No votes yet today — be the first to share your view!

About Aimei Health Technology Co., Ltd (NASDAQ:AFJK) Stock

Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York. ...

AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.

2026-07-08 17:00:00

Aimei Health Technology Co. , Ltd. Announces Termination of Business Combination Agreement NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co. , Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the "Company") announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc.

AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.

2026-07-08 17:00:00

Aimei Health Technology Co., Ltd. Announces Termination of Business Combination Agreement NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the “Company”) announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc. (“United Hydrogen”) and the other parties thereto.

AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORT

2026-05-20 16:05:00

New York, NY, May 20, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co. , Ltd (the "Company") (Nasdaq: AFJK) today announced that on May 19, 2026, it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the "Quarterly Report") with the U.

AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORT

2026-05-20 16:05:00

New York, NY, May 20, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that on May 19, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Quarterly Report”) with the U.S. Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The Quarterly Report was due on May 15, 2026.

Frequently Asked Questions

What is the current Aimei Health Technology Co., Ltd (AFJK) stock price?

Aimei Health Technology Co., Ltd(NASDAQ:AFJK) stock price is $12 in the last trading session. During the trading session, AFJK stock reached the peak price of $130.37 while $6.75 was the lowest point it dropped to. The percentage change in AFJK stock occurred in the recent session was 0.0% while the dollar amount for the price change in AFJK stock was $0.

AFJK's industry and sector of operation?

The NASDAQ listed AFJK is part of Shell Companies industry that operates in the broader Financial Services sector.

Who are the executives of AFJK?

Junheng Xie | Chief Executive Officer, Secretary & Director
Heung Ming Wong | Chief Financial Officer & Director
|
|
|

How many employees does AFJK have?

Number of AFJK employees currently stands at 2. AFJK operates from 10 East 53rd Street, New York City, NY 10022, US.

Link for AFJK official website?

Official Website of AFJK is: https://www.aimeihealth.com

How do I contact AFJK?

AFJK could be contacted at phone #212 845 9945 and can also be accessed through its website. AFJK operates from 10 East 53rd Street, New York City, NY 10022, US.

How many shares of AFJK are traded daily?

The average number of AFJK shares traded daily for last 3 months was 11.43K.

What is the market cap of AFJK currently?

The market value of AFJK currently stands at $73.46M with its latest stock price at $12